We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
“Boston is the largest global hub for cell and gene therapy R&D, so there is also a great pool of local talent and expertise to draw from,” said Vibalogics CEO Tom Hochuli. Read More
A United Nations-backed agency announced yesterday that 18 generic drug manufacturers have pledged to cooperate to speed up access to COVID-19 treatments for low- and middle-income countries. Read More
Pfizer and BioNTech, current frontrunners in the race for an approved COVID-19 vaccine, have finalized an agreement with the European Commission to supply 300 million doses of their vaccine starting by year’s end — but the vaccine’s distribution is expected to face serious challenges worldwide because it must be stored at super-cold temperatures. Read More